(Q43042145)

12 November 2017

title

HIV-1 and HCV viral load cost models for bDNA: 440 Molecular System versus real-time PCR AmpliPrep/TaqMan test (English)

1 reference

12 November 2017

1 reference

Tarek Elbeik

1

1 reference

12 November 2017

Ralph Dalessandro

series ordinal

2

1 reference

12 November 2017

Richard A Loftus

series ordinal

3

1 reference

12 November 2017

Scott Beringer

series ordinal

4

1 reference

12 November 2017

publication date

1 November 2007

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

12 November 2017

published in

1 reference

12 November 2017

volume

7

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

723-753

1 reference

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

HIV viral load monitoring in resource-limited regions: optional or necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

The battle against infectious diseases in developing countries: the inseparable twins of diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Global cost modeling analysis of HIV-1 and HCV viral load assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Labor and cost requirements of two commercial assays for qualitative molecular detection of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Branched DNA technology in molecular diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Molecular assays for monitoring HIV infection and antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

HIV-1 viral load assays for resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

HIV-1 viral load assays for resource-limited settings: clades matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

Evaluation of the VACUTAINER PPT Plasma Preparation Tube for use with the Bayer VERSANT assay for quantification of human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.723

21 January 2018

Identifiers

DOI

10.1586/14737159.7.6.723

1 reference

12 November 2017

1 reference